James Richardson

James Richardson began their work experience in 2009 as a Research Fellow at the University of Southampton, where they focused on investigating the multiplex potential of fluorescent DNA probes and supervised undergraduate students. James also collaborated on multidisciplinary research projects and managed laboratory duties. In 2010, they worked as a Research Scientist at ATDBio, where they improved strategies for probe design and nucleic acid amplification and assisted customers with fluorophore selection and probe design.

In 2011, Richardson returned to the University of Southampton as a Research Fellow, where they developed a point of care package for the rapid detection of Chlamydia. James managed various aspects of the project, including research, financial reporting, and project collaboration.

In 2013, they joined Illumina, starting as an Integration Scientist 1 and later progressing to Senior Integration Scientist and Staff Integration Scientist roles. In these positions, Richardson worked on developing new sequencing systems and integrated lab solutions, led project teams, and collaborated with product development teams and key customers to ensure product functionality in complex customer labs and novel applications. James also contributed to product design, engaged in pre-sales activities, and influenced cloud-based applications, lab automation, and hardware systems.

Most recently, Richardson joined Camena Bioscience in 2023 as the VP of Research and Development. Details about their specific role and responsibilities are not provided.

James Richardson earned a Ph.D. in DNA Chemistry from the University of Southampton, where they studied from 2005 to 2009. Prior to their Ph.D., they completed a Bachelor of Science degree in Chemistry at the same university, from 2002 to 2005. In addition to their academic qualifications, James has obtained certifications in "Cert Prep: PMI Agile Certified Practitioner (PMI-ACP)" from LinkedIn in January 2020 and in "Learning REST APIs" from LinkedIn in October 2018.